NCT03214094View on ClinicalTrials.gov

"Special Drug Use Surveillance of Vonoprazan for Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Low-dose Aspirin: Long-term Use"

CompletedOBSERVATIONAL
Enrollment

1,119

Participants

Timeline

Start Date

September 1, 2016

Primary Completion Date

February 28, 2019

Study Completion Date

February 28, 2019

Conditions
Gastric or Duodenal Ulcers
Interventions
DRUG

Vonoprazan

Vonoprazan tablets

Trial Locations (1)

Unknown

Takeda Selected Site, Tokyo

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY

NCT03214094 - "Special Drug Use Surveillance of Vonoprazan for Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Low-dose Aspirin: Long-term Use" | Biotech Hunter | Biotech Hunter